Clinical Trials Browser

Phase 1/2 × NIH × Neoplasms, Second Primary × Clear all

NCT00166686 2013-01-11

Clonidine for Neurocognitive Sequelae

Phase 1/2 Withdrawn

Neoplasms, Neoplasms, Second Primary